The Primary Care Guide to New CGM Devices and the AGP

Slides:

Advertisements

Similar presentations

Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.

Advertisements

Dry Eye Disease: Pathophysiology, Symptoms, Intervention

Type 1 Diabetes: Meters, Pumps, and Transitions to Adulthood

Diabetic Dyslipidemia in Practice

PrEP: A Case-by-Case Approach

COPD by the Guidelines.

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

New Guidelines to Prevent SCD: What You Need to Know

Monitoring and Management of Adult Relapsed/Refractory Acute Promyelocytic Leukemia.

Lifestyle and Professional CGM

Improving the Diagnosis and Treatment of Seizures in Long-term Care

Special Consideration in Insulin Therapy

Faster-Acting Insulins

Program Goals. Inhaled Insulin: Overcoming Past Obstacles With Advances in Understanding.

Using the AGP to Standardize Glucose Reporting

New Patient-Friendly Options for Managing Insulin Dosing

T2T Guidelines Promote Shared Decision-Making

Introduction ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More.

Modern Strategies for Basal Insulin Use in T2D

COPD Management.

The Comprehensive Major Depressive Disorder Care Team

What Comes Second?.

Updates on Outcomes for Novel T2D Therapies

How Early Should Basal Insulin Be Used in T2D Management?

Updates in Management of Atopic Dermatitis From Real Patient Cases

Is Your Patient Engaged in Care

Updates Abound.

Best Practices in Advanced Glucose Monitoring

SGLT2 Inhibitors in the Modern Era: Why and Where?

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Examining CV Effects of Basal Insulin Therapy

Updates to Managing Diabetes in the Long-Term Care Setting

Goals. Achieving HbA1c Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes.

THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES

Navigating the Data and Evolving Our Approach

A: Percentage of type 1 diabetic and type 2 diabetic patients with asymptomatic hypoglycemias detected by the CGMS. B: Daily distribution of asymptomatic.

Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?

Hyperhidrosis Is Burdensome!

Understanding Comparative Effectiveness Data in Psoriatic Arthritis

Novel Approaches in T1D Management

Battling Constipation

HIV Treatment: What Can You Do to Get and Keep Patients in Care?

Simplifying Insulin Delivery for Better Patient Outcomes in T2D

Predictive Low Glucose Suspend (PLGS)

Novel Approaches to T1D Management

Glucose Monitoring: An Evolving Landscape

This CGM tracing of a 28-year-old patient with a 15-year history of type 1 diabetes demonstrates the occurrence of hypoglycemia unawareness lasting from.

Better Diabetes Control With Novel Basal Insulins

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Modern Advances in Glucose Monitoring

Guide to Atopic Dermatitis

Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?

Panelists. Cardiovascular Risk Modulation in Diabetes: Emerging Pathways and Insights.

Dual SGLT1/SGLT2 Inhibition in T1D

Defining Patient-Centered Care: Spotlight on Advanced Non-Small Cell Lung Cancer.

Hypoglycemia: The Most Common Barrier to Effective Diabetes Management

Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC

A Guideline-Based Approach to HCV Care

Critical Decision Points in Insomnia

NP and PA Expert Exchange:

Challenges in LA SCCHN.

Improving Overall Health

Gadolinium Update.

THE CONTINUUM OF CARE IN mCRC: OPTIMIZING USE OF EGFR ANTIBODIES

Patient and Clinician Perspectives on Preventive Therapy for Migraine

What's New in Oral Combination Therapy for Type 2 Diabetes?

Care Team Collaboration for CAR T-Cell Therapy: Real-World Advice

New Advances in Hybrid Closed-Loop Control of Insulin Therapy

Fresh perspectives ON BASAL Insulins in diabetes care

Taking a Closer Look at Probiotic Efficacy

Presentation transcript:

The Primary Care Guide to New CGM Devices and the AGP

Introduction

HbA1c: Pros and Cons

SMBG Pros and Cons

CGM Technology Real-Time Glucose

Glucose Pattern Summary and AGP

Sample Report CGM Glucose Pattern Summary for a Patient With T1D

The AGP

The AGP (cont)

Hypoglycemia Identified From the AGP

The Daily Glucose Summary

Sample Report CGM Glucose Pattern Summary for a Patient With T2D

The AGP

Identifying Hypoglycemic Episodes

This Patient With T2D Had 4 Episodes of Hypoglycemia

CGM and the AGP Key Takeaways

Currently Available Personal CGM Products

Reimbursement for CGM

Currently Available Professional CGM Products

Medicare Guidelines for CGM

CGM-Based Decisions Can Promote Improved Glucose Control Among CGM Users

Engaging Patients

Concluding Remarks

Abbreviations